ELLEN-MARIE KENNY: Open Payments
NPI 1740423680 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 24 payments from 9 companies in 2025. Trend: 2023 $598 · 2024 $523 · 2025 $653
Food & beverage: $554Education: $99
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 16 | $374 |
| Actelion Pharmaceuticals US, Inc. | 1 | $99 |
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| PFIZER INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
Products named: AVEIR, OPSUMIT, CARDIOMEMS, JOT DX, AMVUTTRA, LEQVIO, JARDIANCE, ELIQUIS.
Industry payments across NY — which companies pay providers there.
